Literature DB >> 7656634

Bacteremic nosocomial pneumonia. A 7-year experience in one institution.

G D Taylor1, M Buchanan-Chell, T Kirkland, M McKenzie, R Wiens.   

Abstract

STUDY OBJECT: To describe the epidemiology, microbiology, and outcome of nosocomial pneumonia with secondary bloodstream infection.
DESIGN: Prospective cohort study.
SETTING: Tertiary care Canadian teaching hospital. PATIENTS: Inpatients. MEASUREMENT: All inpatient blood cultures were concurrently monitored over an 89 month period. Following chart review, patients experiencing nosocomial bloodstream infection due to pneumonia were identified. A standardized definition of pneumonia was used.
RESULTS: One hundred forty-nine episodes occurred in 145 patients, 0.66/1,000 hospital admissions, 8.4% of all nosocomial bloodstream infections. No change in rate occurred in the study period. Fifty-four percent of episodes developed in one of seven ICUs. Staphylococcus aureus was the most frequently identified etiologic organism (27%). The ICU and non-ICU cases did not differ in etiology. No organism became more prevalent during the study period. Twenty percent of patients died within 1 week of first positive culture; episodes associated with Pseudomonas species had a much higher mortality rate (45%) than other infections (14%) (p = 0.002). The ICU and non-ICU infections had a similar mortality rate.
CONCLUSION: Pneumonia is an important cause of nosocomial bloodstream infection, but it is not increasing in frequency or changing in etiology in our institution. The ICUs are a major contributor to this problem but have the same case short-term mortality rate and microbial etiology as non-ICU cases. Cases associated with Pseudomonas have a much higher mortality rate.

Entities:  

Mesh:

Year:  1995        PMID: 7656634     DOI: 10.1378/chest.108.3.786

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production.

Authors:  Alayne Cuzick; Fiona R Stirling; Susan L Lindsay; Thomas J Evans
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

3.  Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  M Pujol; X Corbella; C Peña; R Pallares; J Dorca; R Verdaguer; A Diaz-Prieto; J Ariza; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

4.  Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.

Authors:  E J Ernst; S Hashimoto; J Guglielmo; T Sawa; J F Pittet; H Kropp; J J Jackson; J P Wiener-Kronish
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.

Authors:  K Kurahashi; O Kajikawa; T Sawa; M Ohara; M A Gropper; D W Frank; T R Martin; J P Wiener-Kronish
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.

Authors:  C Jaccard; N Troillet; S Harbarth; G Zanetti; D Aymon; R Schneider; R Chiolero; B Ricou; J Romand; O Huber; P Ambrosetti; G Praz; D Lew; J Bille; M P Glauser; A Cometta
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Long term trends in the occurrence of nosocomial blood stream infection.

Authors:  G Taylor; M Buchanan-Chell; T Kirkland; M McKenzie; R Wiens
Journal:  Can J Infect Dis       Date:  2000-01

8.  Infectious background of febrile advanced lung cancer patients who received chemotherapy.

Authors:  Katsuhiro Masago; Akiko Fukuhara; Yutaka Ito; Yukimasa Hatachi; Kaoru Irisa; Yuichi Sakamori; Yosuke Togashi; Shiro Fujita; Young Hak Kim; Tadashi Mio; Michiaki Mishima
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

9.  In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections.

Authors:  T Sawa; M Ohara; K Kurahashi; S S Twining; D W Frank; D B Doroques; T Long; M A Gropper; J P Wiener-Kronish
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.